Tofacitinib 5 mg (Tofacent): A Promising Medicine for Liver and Breast Cancer
Tofacitinib, commonly marketed under the brand name Tofacent, is a small molecule drug initially developed as a Janus kinase (JAK) inhibitor for the treatment of autoimmune diseases like rheumatoid arthritis. Recently, its potential applications in oncology, particularly in liver and breast cancer, have garnered significant attention. Mechanism of